CLINICAL_TRIALS
research
· 2007-09-05
Clinical Trial Update: RiSolubles™, the Soluble Fraction of Rice Bran for HIV-Infected Patients [Phase 2]
Summary
Clinical trial update on RiSolubles™, the soluble fraction of rice bran, for HIV infection in a Phase 2 study.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hadassah Medical Organization | Conditions: HIV Infections | Phase 2 | Status: UNKNOWN